Macrolide antibiotics are widely prescribed for the treatment of respiratory tract infections; however, the increasing prevalence of macrolide-resistant pathogens is a public health concern. Therefore, the development of new macrolide derivatives with activities against resistant pathogens is urgently needed. A series of novel 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides has been synthesized from erythromycin A. These compounds have shown very promising in vitro and in vivo antibacterial activities against key respiratory pathogens including erythromycin-susceptible/resistant strains.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.06.092 | DOI Listing |
Publication Analysis
Top Keywords
6-o-heteroaryl-isoxazolylpropynyl 2-fluoro
8
2-fluoro ketolides
8
synthesis antibacterial
4
antibacterial activity
4
activity 6-o-heteroaryl-isoxazolylpropynyl
4
ketolides macrolide
4
macrolide antibiotics
4
antibiotics prescribed
4
prescribed treatment
4
treatment respiratory
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!